Deals
Linklaters has signed three private equity deals in one day, advising Triton Partners on the sale of Dematic to AEA Investors and Teachers’ Private Capital, the private equity arm of Canadian pension fund, Ontario Teachers’ Pension Plan (OTPP).
Dematic was founded in 1819 and, in 1973, became part of steel and machine group Mannesmann, which then sold it to Siemens. Triton acquired Dematic in 2006.
Initially run as an auction, this complicated transaction involved running a high yield bond prior to the sale itself for which ACA and OTPP are using US financing to support the acquisition.
The transaction was
Funds advised by Triton have sold logistics specialist Dematic to private equity investor AEA Investors and Teachers’ Private Capital (TPC), the private equity arm of Canadian pension fund Ontario Teachers’ Pension Plan.
As part of the transaction, around EUR450m of outstanding bonds will be redeemed.
Dematic has sales of approximately EUR1bn and serves worldwide customers with around 4,500 employees across the globe. The parties to the transaction have agreed not to disclose the purchase price.
“Today we are particularly well positioned in the growing retail and e-commerce segments. AEA and TPC have the track record, know-how and capital to support
The aggregate value of technology mergers and acquisitions (M&A) fell 52 per cent year-on-year (YOY) and 15 per cent compared with the previous quarter to USD28.2bn in the third quarter of 2012, according to Ernst & Young’s Global technology M&A update.
Large M&A transactions gave way to smaller, more strategic deals, as companies proceeded cautiously in light of continued, widespread macroeconomic uncertainty.
In particular, the total volume of announced deals in 3Q12 was 752, up two per cent YOY and three per cent sequentially (on 2Q12). Strategic transactions continue to be driven by five long-term megatrends that are generating disruptive
Synerlab, a French pharmaceutical contract manufacturing firm, and AXA Private Equity have acquired Lyofal and IDD-Tech Orleans.
Lyofal, a company founded and managed by Jean-Luc Allemand, specialises in custom-lyophilisation (freeze-drying) while IDD-Tech Orleans specialises in the development of solid dosage forms.
With these acquisitions, Synerlab reinforces its leading market position and becomes a company with five sites, employing 700 people, and a turnover of EUR85m.
Lyofal’s longstanding expertise and excellent facilities will allow the Synerlab Group to extend its range of products and enter the attractive and growing lyophilization market. Synerlab will also benefit from Lyofal’s strong client portfolio, which
Law firm Taylor Wessing has advised Rutland Partners on the acquisition of Pizza Hut’s UK dine-in restaurant business from Yum! Brands, the global owners of the Pizza Hut brand.
In the deal, Rutland acquired the share capital of Pizza Hut UK, the company which owns 330 dine in restaurants and will operate them under a franchise agreement from Yum!
Rutland will invest GBP20m in support of a broad GBP60m refurbishment and restructuring programme of the business.
Yum! will continue to act as franchisor for the dine in business whilst also growing the Pizza Hut delivery business in the UK.
Nick
Law firm Clifford Chance has advised CCM Pharma Midco, a vehicle formed by Cinven Funds, on its purchase of Amdipharm.
The transaction values Amdipharm at GBP365m.
Amdipharm is a family-owned international niche pharmaceuticals business founded by Bhikhu and Vijay Patel, which buys "legacy products" – typically off-patent generic drugs in niche disease areas.
Cinven client relationship partner Jonny Myers says: "Clifford Chance is delighted to have advised Cinven on this deal, the second acquisition we have worked on together in as many months."
In August the firm acted for Cinven on its acquisition of the generics business Mercury Pharma. The
The offshore M&A market was one of the few world markets to have experienced growth in the cumulative value of transactions in Q3 2012 compared to the same period last year, according to a report released by Appleby.
The latest edition of Offshore-i, the firm’s quarterly report which provides data and insight on merger and acquisition activity in major offshore financial centres, focuses on Q3 2012.
In the third quarter of 2012 there was a 10 per cent drop in the volume, and a 17 per cent drop in the value, of transactions that took place offshore compared to Q2.
MNX, a provider of transportation and logistics services, has been acquired by private equity firm The Riverside Company.
The deal will provide MNX with the ability to fund future expansion and acquisitions.
"MNX’s compelling service offerings and continued international expansion have contributed to a strong pipeline of opportunities that position the company for growth," says MNX chief executive Scott Cannon. "Riverside has a stellar reputation for helping companies accelerate development. We believe the acquisition marries nicely with our existing expansion plans while also benefiting our existing customers and employees. We could not be more thrilled about the opportunities presented by
Edmond de Rothschild Investment Partners’ portfolio company Vessix Vascular has been acquired by Boston Scientific in a deal worth up to USD425m.
Of this, USD125m will be paid at the closing with the balance upon achievement of certain clinical and sales milestones.
Vessix has developed a catheter-based renal denervation system for the treatment of uncontrolled hypertension.
Edmond de Rothschild Investment Partners holds a significant stake in Vessix in which it invested USD10m in June 2011 generating a return multiple of up to 10x.
Raphaël Wisniewski, Edmond de Rothschild Investment Partners’ representative on Vessix’s board, says: "We are proud to have
Maitland, a provider of fund administration, multi-jurisdictional legal, tax, fiduciary and investment advisory services, has acquired Admiral Administration.
Admiral is a hedge fund administrator with offices in the Cayman Islands; Dublin, Ireland; Halifax, Nova Scotia; and Richmond, Virginia.
It combines best of breed technology including Advent Geneva, Advent Partner and Paladyne with qualified staff to provide clients with a customised solution to meet the specific needs of the alternative investments industry including hedge funds, private equity funds, Ucits and other regulated funds.
The acquisition of Admiral supports Maitland’s strategy of targeted growth, expanded global reach and leadership in the fund
Events
12 November, 2026 – 8:00 am
12 November, 2026 – 5:00 pm
